LEARN HOW TO REDUCE YOUR ORTHOPEDIC SPEND TRAJECTORY BY OVER 80% AND PROVIDE YOUR EMPLOYEES AN OPTION TO INVASIVE SURGICAL CARE THAT THEY CHOOSE OVER 99.7% WHEN THE REGENEXX PROCEDURES ARE ADDED TO YOUR HEALTH PLAN
Announcing Major Changes to Support Client Demand
I am pleased to announce a major milestone unique to Regenexx that makes Interventional Orthopedics available to large corporate employers with ubiquitous support at the local, regional and national level. Regenexx is the pioneer of stem cell treatments in the United States and is now the first Interventional Orthopedic company with a national clinic network to support corporate client operations. We have over 30 years experience in insurance expertise to make the process of adding our procedures seamless and at no cost for clients to implement.
As of October 1st…We have reduced our corporate partners’ orthopedic costs by 81%* at an overall savings of over $5.1 MILLION dollars with an average patient improvement at 6 months of 80%.
Promoting Your Employee’s Wellbeing through the Nations Leader in Regenerative Medicine
Updates and Findings From Regenexx®
- The Difference Between Amniotic Stem Cell Scams and Regenexx
- Why A Bone Marrow Stem Cell Procedure Should Keep More of the Good Stuff Around
- Ignoring Chronic Pain May Lead to Early Death
- Regenexx Lab Research is Second to None
We look forward to showing you how our corporate program helps companies just like yours save money while contributing to employee wellbeing and orthopedic health.
* This data was calculated based on the gross savings realized from substituting percutaneous orthobiologic procedures for invasive, elective orthopedic surgeries within our pilot program in Des Moines, IA. Now that we have more data from more clients, we will update our cost savings on a quarterly basis using a sampling methodology, later this year we will be introducing an actuarial based process.